Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?' by Nocturne et al

Ann Rheum Dis. 2017 Feb;76(2):e4. doi: 10.1136/annrheumdis-2016-210631. Epub 2016 Dec 1.
No abstract available

Keywords: Anti-TNF; Outcomes research; Rheumatoid Arthritis.

Publication types

  • Letter
  • Comment

MeSH terms

  • Antirheumatic Agents*
  • Arthritis, Rheumatoid*
  • Humans
  • Lymphoma*

Substances

  • Antirheumatic Agents